中国医学创新
中國醫學創新
중국의학창신
MEDICAL INNOVATION OF CHINA
2013年
33期
27-28
,共2页
康妇消炎栓%盐酸莫西沙星%盆腔炎%治疗
康婦消炎栓%鹽痠莫西沙星%盆腔炎%治療
강부소염전%염산막서사성%분강염%치료
Kangfute inflammatory suppository%Moxifloxacin hydrochloride%Pelvic inflammatory disease%Treatment
目的：探讨盐酸莫西沙星联合康妇消炎栓治疗盆腔炎的临床疗效。方法：选取116例盆腔炎患者，随机分为对照组和治疗组，每组58例。对照组采用盐酸莫西沙星治疗；治疗组采用盐酸莫西沙星联合康妇消炎栓治疗。比较两组患者治疗前后TNF-α和CRP水平改善幅度、症状消失时间、接受临床治疗总时间、盆腔炎病情治疗效果、治疗期间药物不良反应、停止治疗后病情复发率等指标。结果：治疗后，对照组盆腔炎病情治疗总有效率为72.4%，治疗组为91.4%，两组比较差异有统计学意义（P<0.05）；治疗组症状表现消失时间和接受临床治疗总时间明显短于对照组（P<0.05）；治疗期间，治疗组出现药物不良反应率明显少于对照组（P<0.05）；治疗组治疗前后TNF-α和CRP水平改善幅度明显大于对照组（P<0.05）；停止治疗后，治疗组盆腔炎病情复发率明显低于对照组（P<0.05）。结论：盐酸莫西沙星联合康妇消炎栓治疗盆腔炎临床疗效确切，值得推广应用。
目的：探討鹽痠莫西沙星聯閤康婦消炎栓治療盆腔炎的臨床療效。方法：選取116例盆腔炎患者，隨機分為對照組和治療組，每組58例。對照組採用鹽痠莫西沙星治療；治療組採用鹽痠莫西沙星聯閤康婦消炎栓治療。比較兩組患者治療前後TNF-α和CRP水平改善幅度、癥狀消失時間、接受臨床治療總時間、盆腔炎病情治療效果、治療期間藥物不良反應、停止治療後病情複髮率等指標。結果：治療後，對照組盆腔炎病情治療總有效率為72.4%，治療組為91.4%，兩組比較差異有統計學意義（P<0.05）；治療組癥狀錶現消失時間和接受臨床治療總時間明顯短于對照組（P<0.05）；治療期間，治療組齣現藥物不良反應率明顯少于對照組（P<0.05）；治療組治療前後TNF-α和CRP水平改善幅度明顯大于對照組（P<0.05）；停止治療後，治療組盆腔炎病情複髮率明顯低于對照組（P<0.05）。結論：鹽痠莫西沙星聯閤康婦消炎栓治療盆腔炎臨床療效確切，值得推廣應用。
목적：탐토염산막서사성연합강부소염전치료분강염적림상료효。방법：선취116례분강염환자，수궤분위대조조화치료조，매조58례。대조조채용염산막서사성치료；치료조채용염산막서사성연합강부소염전치료。비교량조환자치료전후TNF-α화CRP수평개선폭도、증상소실시간、접수림상치료총시간、분강염병정치료효과、치료기간약물불량반응、정지치료후병정복발솔등지표。결과：치료후，대조조분강염병정치료총유효솔위72.4%，치료조위91.4%，량조비교차이유통계학의의（P<0.05）；치료조증상표현소실시간화접수림상치료총시간명현단우대조조（P<0.05）；치료기간，치료조출현약물불량반응솔명현소우대조조（P<0.05）；치료조치료전후TNF-α화CRP수평개선폭도명현대우대조조（P<0.05）；정지치료후，치료조분강염병정복발솔명현저우대조조（P<0.05）。결론：염산막서사성연합강부소염전치료분강염림상료효학절，치득추엄응용。
Objective: To explore the clinical effect of moxifloxacin hydrochloride combined with Kangfute inflammatory suppository in treatment of pelvic inflammatory disease.Method: One hundred and sixteen patients of pelvic inflammatory disease were randomly divided into the control group and the treatment group, each group of 58 cases. The control group was treated by moxifloxacin hydrochloride. The treatment group was treated by Kangfute inflammatory suppository combined with moxifloxacin hydrochloride. The indicators between the two groups were compared after treatment, such as the effective rate, the symptoms disappear time, total time for clinical treatment, adverse drug reactions, improved amplitude of TNF-α and CRP levels, the cessation treatment relapse rate and so on. Result:The effective rate of the control group was 72.4% while the treatment group was 91.4% after treatment, and the difference between the two groups were statistically significant(P<0.05). The symptoms disappear time and total time for clinical treatment of the treatment group were significantly shorter than the control group(P<0.05)and adverse drug reactions rate during treatment of the treatment group were significantly less than the control group(P<0.05).The improved amplitude of TNF-α and CRP levels of the treatment group were significantly higher than the control group after treatment(P<0.05)and the cessation treatment relapse rate of the treatment group was significantly lower than the control group(P<0.05).Conclusion: The clinical effect of moxifloxacin hydrochloride combined with Kangfute inflammatory suppository in treatment of pelvic inflammatory disease is excellent. It is worth popularization and application.
